Rockwell Medical (RMTI) Amortization of Deferred Charges (2014 - 2026)
Rockwell Medical (RMTI) reported Amortization of Deferred Charges of $88000.0 for Q1 2026, little changed on a YoY basis from $88000.0 in Q1 2025, and down 1.12% quarter-over-quarter from $89000.0 in Q4 2025.
Rockwell Medical (RMTI) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends
Rockwell Medical has reported Amortization of Deferred Charges for 11 years, with the latest figure at $88000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $88000.0; the trailing twelve-month figure through Mar 2026 stood at $354000.0 (up 20.0% YoY), and the FY2025 full-year result was $354000.0, down 16.9% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $88000.0, down from $89000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $831000.0 in Q4 2023, with the low at $30000.0 in Q2 2024.
- Historically, Amortization of Deferred Charges has averaged $137882.4 across 5 years, with a median of $92000.0 in 2022.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges jumped 793.55% — and 2024, when it slumped 89.29%.
- Rockwell Medical's Amortization of Deferred Charges stood at $93000.0 in 2022, then jumped by 793.55% to $831000.0 in 2023, then tumbled by 89.29% to $89000.0 in 2024, then changed by 0.0% to $89000.0 in 2025, then declined by 1.12% to $88000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $88000.0 (Q1 2026), $89000.0 (Q4 2025), and $89000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Rockwell Medical | 27.32 Mn | 3.43 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 88,000.00 |
| Sep 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Dec 31, 2023 | 831,000.00 |
| Dec 31, 2023 | 831,000.00 |